Medical Condition

liver metastases

Total Trials

8

Recruiting Now

8

Trial Phases

Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for liver metastases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — liver metastases Clinical Trials

How many clinical trials are currently recruiting for liver metastases?

ClinicalMetric currently tracks 8 actively recruiting clinical trials for liver metastases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for liver metastases?

liver metastases research spans Phase 1 (2 trials), Phase 2 (2 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a liver metastases clinical trial?

Eligibility criteria for liver metastases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

University of Wisconsin, Madison 1 trial

M.R. Meijerink 1 trial

AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 1 trial

University Health Network, Toronto 1 trial

Fudan University 1 trial

Recruiting Clinical Trials

NCT04020276

Recruiting

OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases

University of Wisconsin, Madis...

View Trial →

NCT06630624 Phase 1, Phase 2

Recruiting

Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

NCT07053488 Phase 1, Phase 2

Recruiting

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

AMERICAN ORGAN TRANSPLANT AND ...

View Trial →

NCT02864485

Recruiting

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

University Health Network, Tor...

View Trial →

NCT04687631 Phase 3

Recruiting

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

Promoting Immunotherapy Efficacy With Low-Dose Liver RT

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases

Related Conditions

colorectal cancer (3) liver cancer (2) stereotactic body radiation therapy (1) mri guided treatment (1) liver metastasis colon cancer (1) liver diseases (1) liver cirrhosis (1) liver failure (1) liver transplant rejection (1) liver steatoses (1) low dose liver radiation ld lrt (1) non small cell lung cancer (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology